PT3116498T - Formulação para análogos anticolinérgicos suaves - Google Patents

Formulação para análogos anticolinérgicos suaves

Info

Publication number
PT3116498T
PT3116498T PT15762178T PT15762178T PT3116498T PT 3116498 T PT3116498 T PT 3116498T PT 15762178 T PT15762178 T PT 15762178T PT 15762178 T PT15762178 T PT 15762178T PT 3116498 T PT3116498 T PT 3116498T
Authority
PT
Portugal
Prior art keywords
anticolinergical
analogs
formulation
soft
soft anticolinergical
Prior art date
Application number
PT15762178T
Other languages
English (en)
Portuguese (pt)
Inventor
S Bodor Nicholas
Angulo David
J Koleng John
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Publication of PT3116498T publication Critical patent/PT3116498T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
PT15762178T 2014-03-13 2015-03-12 Formulação para análogos anticolinérgicos suaves PT3116498T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461952505P 2014-03-13 2014-03-13
US14/285,488 US20150259283A1 (en) 2014-03-13 2014-05-22 Formulation for soft anticholinergic analogs

Publications (1)

Publication Number Publication Date
PT3116498T true PT3116498T (pt) 2019-02-11

Family

ID=54068191

Family Applications (2)

Application Number Title Priority Date Filing Date
PT15762178T PT3116498T (pt) 2014-03-13 2015-03-12 Formulação para análogos anticolinérgicos suaves
PT168285534T PT3325487T (pt) 2014-03-13 2016-07-21 Formulação para análogos anticolinérgicos lisos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT168285534T PT3325487T (pt) 2014-03-13 2016-07-21 Formulação para análogos anticolinérgicos lisos

Country Status (20)

Country Link
US (8) US20150259283A1 (enrdf_load_stackoverflow)
EP (1) EP3116498B1 (enrdf_load_stackoverflow)
JP (5) JP6293919B2 (enrdf_load_stackoverflow)
KR (3) KR20230145522A (enrdf_load_stackoverflow)
CN (3) CN110420167B (enrdf_load_stackoverflow)
AU (2) AU2015229243B2 (enrdf_load_stackoverflow)
BR (1) BR112016021011B1 (enrdf_load_stackoverflow)
CA (1) CA2941649C (enrdf_load_stackoverflow)
DK (2) DK3116498T3 (enrdf_load_stackoverflow)
ES (1) ES2710292T3 (enrdf_load_stackoverflow)
HU (1) HUE041868T2 (enrdf_load_stackoverflow)
IL (1) IL247571B (enrdf_load_stackoverflow)
MX (1) MX369129B (enrdf_load_stackoverflow)
MY (1) MY183531A (enrdf_load_stackoverflow)
PH (1) PH12016501732A1 (enrdf_load_stackoverflow)
PL (1) PL3116498T3 (enrdf_load_stackoverflow)
PT (2) PT3116498T (enrdf_load_stackoverflow)
SG (1) SG11201607480SA (enrdf_load_stackoverflow)
WO (1) WO2015138776A1 (enrdf_load_stackoverflow)
ZA (1) ZA201607071B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180081B2 (en) * 2005-03-03 2015-11-10 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
KR102428738B1 (ko) 2013-08-08 2022-08-02 노반, 인크. 국소 조성물 및 그의 사용 방법
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
CN119033771A (zh) 2015-07-21 2024-11-29 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI719046B (zh) * 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11381304B2 (en) * 2017-08-30 2022-07-05 Iridium Satellite Llc Satellite communications with multiple classes of terrestrial terminal devices
CA3139948A1 (en) * 2019-05-23 2020-11-26 Kaken Pharmaceutical Co., Ltd. Crystalline form of sofpironium bromide and preparation method thereof
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
JPWO2021177257A1 (enrdf_load_stackoverflow) 2020-03-03 2021-09-10
KR20220149550A (ko) 2020-03-03 2022-11-08 가켄 세이야쿠 가부시키가이샤 소피로늄 브로마이드를 포함하는 의약
KR102655121B1 (ko) 2021-09-17 2024-04-08 한국식품연구원 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도
US11807604B1 (en) * 2022-02-16 2023-11-07 Miralogx Llc Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders
WO2024026412A1 (en) * 2022-07-28 2024-02-01 Tff Pharmaceuticals, Inc. Thin film freezing methods and compositions formulated from dispersed active agents
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5143719A (en) 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
GB2280111B (en) 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
CA2461696A1 (en) * 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP1835812B1 (de) * 2004-12-27 2011-08-17 Beiersdorf AG Glycopyrrolat in kosmetischen zubereitungen
CN101340884A (zh) * 2005-10-19 2009-01-07 曼尼·马纳舍·辛格尔 用于治疗多汗症的方法
EP1957451B1 (en) 2005-11-10 2011-10-19 Nicholas S. Bodor Soft anticholinergic zwitterions
EP1948596B1 (en) 2005-11-10 2011-10-19 Nicholas S. Bodor Soft anticholinergic esters
AU2006201878A1 (en) * 2006-03-13 2007-09-27 Foamix Ltd Foamable composition for hyperhidrosis
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
WO2009051818A1 (en) 2007-10-18 2009-04-23 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations
US20100137357A1 (en) * 2008-11-26 2010-06-03 Koleng John J Compositions and methods for hyperhidrosis
US20140037713A1 (en) * 2012-08-03 2014-02-06 Antares Pharma Ipl, Ag Transdermal compositions for anti-cholinergic agents
US9220707B2 (en) * 2013-03-15 2015-12-29 Bodor Laboratories, Inc. Method of dosing and use of soft anticholinergic esters
JP2017507959A (ja) 2014-03-13 2017-03-23 ボドール ラボラトリーズ， インコーポレイテッド 選択された抗コリン作動性両性イオンの使用
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
CN119033771A (zh) 2015-07-21 2024-11-29 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Also Published As

Publication number Publication date
US20150320722A1 (en) 2015-11-12
HUE041868T2 (hu) 2019-05-28
DK3116498T3 (en) 2019-03-11
US11084788B2 (en) 2021-08-10
KR20160133492A (ko) 2016-11-22
PL3116498T3 (pl) 2019-05-31
US20200113869A1 (en) 2020-04-16
BR112016021011A8 (pt) 2021-07-20
JP2020079321A (ja) 2020-05-28
PT3325487T (pt) 2021-07-29
US20150259283A1 (en) 2015-09-17
WO2015138776A1 (en) 2015-09-17
JP2017507970A (ja) 2017-03-23
CA2941649A1 (en) 2015-09-17
US10961191B2 (en) 2021-03-30
CN110917124A (zh) 2020-03-27
MX369129B (es) 2019-10-30
JP6762047B2 (ja) 2020-09-30
MY183531A (en) 2021-02-25
ES2710292T3 (es) 2019-04-24
DK3325487T3 (da) 2021-08-02
JP6293919B2 (ja) 2018-03-14
EP3116498B1 (en) 2018-12-12
CN110420167A (zh) 2019-11-08
JP2018115203A (ja) 2018-07-26
US20170020845A1 (en) 2017-01-26
AU2015229243A1 (en) 2016-10-20
JP2017214429A (ja) 2017-12-07
BR112016021011B1 (pt) 2022-12-13
SG11201607480SA (en) 2016-10-28
JP2019189650A (ja) 2019-10-31
CN106456603B (zh) 2020-01-10
PH12016501732B1 (en) 2017-02-06
ZA201607071B (en) 2018-12-19
KR20220119517A (ko) 2022-08-29
BR112016021011A2 (pt) 2017-08-15
CN106456603A (zh) 2017-02-22
US11034652B2 (en) 2021-06-15
KR102586868B1 (ko) 2023-10-11
US20210078946A1 (en) 2021-03-18
US20210087142A1 (en) 2021-03-25
JP6756763B2 (ja) 2020-09-16
US12398102B2 (en) 2025-08-26
CN110917124B (zh) 2023-06-20
KR102433868B1 (ko) 2022-08-19
IL247571A0 (en) 2016-11-30
AU2019257421B2 (en) 2021-10-21
PH12016501732A1 (en) 2017-02-06
US20210198195A1 (en) 2021-07-01
EP3116498A4 (en) 2017-11-08
KR20230145522A (ko) 2023-10-17
MX2016011529A (es) 2016-12-07
US10947192B2 (en) 2021-03-16
CA2941649C (en) 2021-03-02
IL247571B (en) 2020-03-31
AU2015229243B2 (en) 2019-11-21
CN110420167B (zh) 2023-02-17
EP3116498A1 (en) 2017-01-18
AU2019257421A1 (en) 2019-11-21
JP6461267B2 (ja) 2019-01-30
US20200093791A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
PT3116498T (pt) Formulação para análogos anticolinérgicos suaves
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3194411T3 (da) Nukleotidanaloger
DK3215173T3 (da) Glycopeptidsammensætninger
FR3024363B1 (fr) Composition thermogelifiable
EP3237013C0 (en) TRANSDERMAL FORMULATIONS
PL3182957T3 (pl) Kompozycja zawierająca cyneol do podawania donosowego
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
HUE070090T2 (hu) Összetétel
DK3792251T3 (da) Hidtil ukendte sulfonylaminobenzamidforbindelser som anthelmintika
DK3148513T3 (da) Ceritinib-formulering
DK3200827T3 (da) Sammensætninger
DK3193856T3 (da) Formulering
DK3217964T3 (da) Sammensætning
FR3019552B1 (fr) Composition filmogene
DK3145317T3 (da) Fedtsammensætning
ES1135628Y (es) Monoboya para vertido controlado
ES1148233Y (es) Cinta-faja para bebes
TH1601002207A (th) สูตรผสมใหม่สำหรับโกนาโดโทรพิน
CL2015003549S1 (es) Un implemento para el cuidado oral
ES1145161Y (es) Aguja-Ganchillo para cirugía
ES1135500Y (es) Mesa para efectos de ilusionismo
ES1113530Y (es) Carrusel para ninos
ES1110180Y (es) Corbata-Babero para niños